$121.27+1.63 (+1.36%)
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
iRhythm Holdings, Inc. in the Healthcare sector is trading at $121.27 with a market capitalization of $4.2B. Wall Street consensus targets $171.33 (15 analysts), implying a +41.3% move over the next 12 months. The stock is currently near its 52-week low of $100.70, remaining 1.9% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $224.17Mβ | $199.39Mβ | $208.89Mβ | $192.88Mβ | $186.69M |
| Gross Profit | $163.21Mβ | $141.35Mβ | $148.06Mβ | $137.12Mβ | $132.86M |
| Operating Income | $11.41Mβ | -$16.18Mβ | $4.26Mβ | -$8.43Mβ | -$16.23M |
| Net Income | -$381,000β | -$13.93Mβ | $5.58Mβ | -$5.21Mβ | -$14.22M |
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company ...